These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 32468048)
1. Knockdown of ubiquitin‑specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc‑finger E‑box binding homeobox 1. Zhou F; Du C; Xu D; Lu J; Zhou L; Wu C; Wu B; Huang J Mol Med Rep; 2020 Aug; 22(2):1382-1390. PubMed ID: 32468048 [TBL] [Abstract][Full Text] [Related]
2. CDK4/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1. Li J; Xiao X; Wang H; Wang W; Ou Y; Wang Z; Jiang H; Liu Y; Zhang Z; Yang S Cancer Gene Ther; 2022 Aug; 29(8-9):1181-1192. PubMed ID: 35058607 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7. Pan X; Chen Y; Shen Y; Tantai J Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576 [TBL] [Abstract][Full Text] [Related]
4. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells. Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719 [TBL] [Abstract][Full Text] [Related]
5. USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics. Liu YJ; Zeng SH; Zhang W; Li JP; Yin Y; Zhuang YW; Zhou JY; Liu SL; Zou X Pharmacol Res; 2023 Feb; 188():106644. PubMed ID: 36603607 [TBL] [Abstract][Full Text] [Related]
6. CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism. Zhang Z; Li J; Ou Y; Yang G; Deng K; Wang Q; Wang Z; Wang W; Zhang Q; Wang H; Sun W; Sun P; Yang S Signal Transduct Target Ther; 2020 Mar; 5(1):25. PubMed ID: 32296027 [TBL] [Abstract][Full Text] [Related]
7. The role of USP51 in attenuating chemosensitivity of lung cancer cells to cisplatin by regulating DNA damage response. Zhou F; Lu J; Jin W; Li Z; Xu D; Gu L Biotechnol Appl Biochem; 2023 Apr; 70(2):634-644. PubMed ID: 35856403 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis. Cao L; Zhou X; Ding X; Gao D Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328193 [TBL] [Abstract][Full Text] [Related]
9. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2. He R; Liu H Gene; 2020 Jul; 747():144553. PubMed ID: 32165307 [TBL] [Abstract][Full Text] [Related]
10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
11. Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma. Du H; Chen B; Jiao NL; Liu YH; Sun SY; Zhang YW Oxid Med Cell Longev; 2020; 2020():7370157. PubMed ID: 32215178 [TBL] [Abstract][Full Text] [Related]
12. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin. Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580 [TBL] [Abstract][Full Text] [Related]
13. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910 [TBL] [Abstract][Full Text] [Related]
14. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells. He S; Ma X; Zheng N; Wang G; Wang M; Xia W; Yu D Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355367 [TBL] [Abstract][Full Text] [Related]
15. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9. Liu B; Wang R; Liu H Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989 [TBL] [Abstract][Full Text] [Related]
17. Gambogic Acid Improves Cisplatin Resistance of Bladder Cancer Cells through the Epithelial-Mesenchymal Transition Pathway Mediated by the miR-205-5p/ZEB1 Axis. Mei Y; Xu J; Li W; Chen S Ann Clin Lab Sci; 2024 May; 54(3):354-362. PubMed ID: 39048172 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells. Wang M; Zhang R; Zhang S; Xu R; Yang Q Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930 [TBL] [Abstract][Full Text] [Related]
19. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis. Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768 [TBL] [Abstract][Full Text] [Related]
20. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis. Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]